Sign in

CIK 0001937653 · Non-accelerated filer<br>Smaller reporting company

Zymeworks Inc.

Sign in to watch
Ticker
ZYME
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
883099146
Phone
302-274-8744
Business address
108 PATRIOT DRIVE, SUITE A, MIDDLETOWN, DE, 19709
Former names
Zymeworks Delaware Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$357,557
in 1 filing

Net −$357,557. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Schayowitz Adam −$358K EVP, Head of R&D sold 37% of stake
Date Insider Transaction Shares Price Value Owned after
2023-04-10 Miller Derek John Michael Director Grant or award · Stock Option (Right to Buy) +50,000 50,000
2023-03-28 EcoR1 Capital, LLC 10% owner Purchase +200,000 $8.00 $1.6M 10,087,473
2023-03-10 Klompas Neil A President & COO Option exercise +2,500 17,301
2023-03-10 Klompas Neil A President & COO Option exercise +2,708 20,009
2023-03-10 Klompas Neil A President & COO Sale −2,977 $7.83 $23K 17,032
2023-03-10 Klompas Neil A President & COO Option exercise · Restricted Stock Unit −2,500 0
2023-03-10 Klompas Neil A President & COO Option exercise · Restricted Stock Unit −2,708 2,709
2023-01-20 EcoR1 Capital, LLC 10% owner Purchase +163,400 $9.88 $1.6M 9,887,473
2023-01-19 EcoR1 Capital, LLC 10% owner Purchase +144,100 $9.49 $1.4M 9,724,073
2023-01-18 EcoR1 Capital, LLC 10% owner Purchase +203,000 $10.00 $2.0M 9,579,973
2023-01-17 EcoR1 Capital, LLC 10% owner Purchase +440,000 $9.80 $4.3M 9,376,973
2023-01-13 EcoR1 Capital, LLC 10% owner Purchase +342,100 $9.81 $3.4M 8,936,973
2023-01-11 EcoR1 Capital, LLC 10% owner Purchase +106,300 $7.87 $837K 8,594,873
2023-01-10 EcoR1 Capital, LLC 10% owner Purchase +920,000 $7.65 $7.0M 8,488,573
2023-01-05 Klompas Neil A President & COO Grant or award · Stock Option (Right to Buy) +87,500 87,500
2023-01-05 Klompas Neil A President & COO Grant or award · Restricted Stock Unit +58,500 58,500
2023-01-05 Astle Christopher SVP & Chief Financial Officer Grant or award · Stock Option (Right to Buy) +47,000 47,000
2023-01-05 Astle Christopher SVP & Chief Financial Officer Grant or award · Restricted Stock Unit +31,500 31,500
2023-01-05 Galbraith Kenneth Chair & CEO Grant or award · Stock Option (Right to Buy) +215,000 215,000
2023-01-05 Galbraith Kenneth Chair & CEO Grant or award · Restricted Stock Unit +143,000 143,000

Page 10 of 12 · 224 trades